Published in Drug Discov Today on March 02, 2015
Targeting autophagy to sensitive glioma to temozolomide treatment. J Exp Clin Cancer Res (2016) 0.93
Volatile Oil of Acori Graminei Rhizoma-Induced Apoptosis and Autophagy are dependent on p53 Status in Human Glioma Cells. Sci Rep (2016) 0.80
Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression. Am J Transl Res (2016) 0.79
RLIP76 Depletion Enhances Autophagic Flux in U251 Cells. Cell Mol Neurobiol (2016) 0.77
The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget (2017) 0.76
Overexpression of TELO2 decreases survival in human high-grade gliomas. Oncotarget (2016) 0.75
Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells. Springerplus (2016) 0.75
Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme. Cancer Biol Ther (2016) 0.75
Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas. Theranostics (2017) 0.75
Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties. Int J Mol Sci (2017) 0.75
An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas. Front Mol Neurosci (2017) 0.75
Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma. Oncogene (2017) 0.75
MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor. J Neurooncol (2017) 0.75
In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme. Iran J Med Sci (2017) 0.75